Back to Report Store Home

Frontier Pharma: Hematological Disorders - Iron Regulators and Immune Response Targeted Programs Within Anemias and other Red Blood Cell Disorders Hold Potential to Transform Therapy Area with Significant Unmet Need

  • Published: Aug-2017
  • Report Code: GBIHC449MR
  • Report Format: pdf

Description

List of Tables

Table 1: Hematological Disorders Therapeutics Market, Global, Summary of Signs and Symptoms of Key Hematological Disorders, 2017 14

Table 2: Hematological Disorders Therapeutics Market, Global and US, Estimates of Prevalent Cases of Key Disorders, 2017 22

Table 3: Hematological Disorders Therapeutics Market, Global, Data for XXX as a Molecular Target, 2017 48

Table 4: Hematological Disorders Therapeutics Market, Global, Data for XXX as a Molecular Target, 2017 50

Table 5: Hematological Disorders Therapeutics Market, Global, Data for XXX as a Molecular Target, 2017 51

Table 6: Hematological Disorders Therapeutics Market, Global, Data for XXX as a Molecular Target, 2017 53

Table 7: Hematological Disorders Therapeutics Market, Global, Data for XXX as a Molecular Target, 2017 54

Table 8: Hematological Disorders Therapeutics Market, Global, Data for XXX as a Molecular Target, 2017 56

Table 9: Hematological Disorders Therapeutics Market, Global, Data for XXX as a Molecular Target, 2017 57

Table 10: Hematological Disorders Therapeutics Market, Global, Data for XXX as a Molecular Target, 2017 59

Table 11: Hematological Disorders Therapeutics Market, Global, Data for XXX as a Molecular Target, 2017 60

Table 12: Hematological Disorders Therapeutics Market, Global, Pipeline Programs Targeting Complement Component C6, 2017 61

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$6995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$13990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$20985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards